U.S. markets closed

Chemed Corporation (CHE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
433.25+12.72 (+3.02%)
At close: 4:00PM EST

433.25 0.00 (0.00%)
After hours: 4:38PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close420.53
Bid431.55 x 800
Ask433.18 x 1400
Day's Range417.41 - 436.56
52 Week Range330.01 - 560.00
Avg. Volume96,866
Market Cap6.946B
Beta (5Y Monthly)0.49
PE Ratio (TTM)22.24
EPS (TTM)19.48
Earnings DateApr 26, 2021 - Apr 30, 2021
Forward Dividend & Yield1.36 (0.32%)
Ex-Dividend DateFeb 26, 2021
1y Target Est595.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
3% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Chemed Corp (CHE) Q4 2020 Earnings Call Transcript
    Motley Fool

    Chemed Corp (CHE) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Chemed Corp (NYSE: CHE)Q4 2020 Earnings CallFeb 24, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by, and welcome to the Chemed Corporation Fourth Quarter 2020 Earnings Conference Call.

  • A Look Into Chemed's Price Over Earnings

    A Look Into Chemed's Price Over Earnings

    Looking into the current session, Chemed Inc. (NYSE:CHE) is trading at $481.23, after a 0.11% decrease. Over the past month, the stock decreased by 7.30%, but over the past year, it actually spiked by 9.31%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently below from its 52 week high by 14.07%. The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E indicates that shareholders do not expect the stock to perform better in the future, and that the company is probably undervalued. It shows that shareholders are less than willing to pay a high share price, because they do not expect the company to exhibit growth, in terms of future earnings. View more earnings on CHE Depending on the particular phase of a business cycle, some industries will perform better than others. Chemed Inc. has a lower P/E than the aggregate P/E of 34.86 of the Health Care Providers & Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. There are many limitations to P/E ratio. It is sometimes difficult to determine the nature of the earnings makeup of a company. Shareholders might not get what they're looking for, from trailing earnings. See more from BenzingaClick here for options trades from BenzingaRecap: Chemed Q4 EarningsEarnings Scheduled For February 23, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


    Chemed Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Chemed Corp. (NYSE:CHE) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 10:00 AM Eastern Time.